The BPSC: A prospective study investigating the clinical effect of interventional therapy and the risk factors for bladder cancer and benign prostatic hyperplasia in Chinese population

• Published in: Journal of evidence-based medicine 2018-02, Vol.11 (1), p.64-67
• Main Authors: Zeng, Xian‐Tao, Liu, Tong‐Zu, Gong, Kan, He, Da‐Lin, Wang, Xing‐Huan
• Format: Article
• Language: English
• Subjects: benign prostatic hyperplasia; Bladder cancer; BPSC; evidence‐based medicine; Genital diseases; Hyperplasia; plasmakinetic resection of the bladder; plasmakinetic resection of the prostate; Population; Prostate; risk factor; Risk factors
• ISSN: 1756-5391; 1756-5383; 1756-5391
• DOI: 10.1111/jebm.12290

Bladder cancer and benign prostatic hyperplasia have been two very common diseases among the elderly men, especially with the aging of the population in the world. We have designed a study to investigate the clinical effect of interventional therapy for plasmakinetic resection of the prostate and plasmakinetic resection of the bladder, which is called “BPSC” (The bladder cancer and benign prostatic hyperplasia study in Chinese population). The BPSC is not only a specific study, it is made up of many studies. In this article, we introduced the research background, source, name, study framework, study management and further direction of BPSC project. We hope this process will contribute to the growth of the database through sharing data and enriching the evidence of bladder cancer and benign prostatic hyperplasia in the Chinese population, thereby finally improving the accessibility of these important findings for doctors, researchers, and patients.